Antiresorptive agents increase the effects of exercise on preventing postmenopausal bone loss in women: a meta-analysis.
BACKGROUND AND OBJECTIVES:It remains unknown whether the combination of antiresorptive agents and exercise would generate additive effects on bone mineral density (BMD) in postmenopausal women, though their separate roles in preventing bone loss have been well established. This meta-analysis aimed t...
Main Authors: | Renqing Zhao, Zhengang Xu, Meihua Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4304813?pdf=render |
Similar Items
-
Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women’s health practice
by: Cheung AM, et al.
Published: (2016-09-01) -
Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis
by: Swati Rajput, et al.
Published: (2023-02-01) -
A pilot feasibility randomised controlled trial of bone antiresorptive agents on bone turnover markers in critically ill women
by: Neil R. Orford, et al.
Published: (2024-01-01) -
Evaluation of bone loss in diabetic postmenopausal women
by: Mansoor Karimifar, et al.
Published: (2012-01-01) -
Comparison of antiresorptive agents in the treatment of osteoporosis in older adults
by: Zeynel Abidin Öztürk, et al.
Published: (2022-09-01)